Cefepime Hydrochloride And Dextrose Injection, Solution
Product Images NDC 0264-3193

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Cefepime Hydrochloride And Dextrose (NDC 0264-3193). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by B. Braun Medical Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Diagram 1 (Cefepime For Injection In Duplex 1)

FDA Label Image

Cefepime For Injection In Duplex 10

Cefepime For Injection In Duplex 10
This is a label on a drug chamber packaging. It provides instructions to peel the foil strip only when ready to use and discard the unit if the strip is damaged. It also advises visually inspecting the drug prior to reconstitution and provides a reference to the package insert for complete directions on reconstitution and administration.*
FDA Label Image

Diagram 2 (Cefepime For Injection In Duplex 2)

FDA Label Image

Diagram 3 (Cefepime For Injection In Duplex 3)

FDA Label Image

Diagram 4 (Cefepime For Injection In Duplex 4)

FDA Label Image

Diagram 5 (Cefepime For Injection In Duplex 5)

FDA Label Image

Chemical Structure (Cefepime For Injection In Duplex 6)

FDA Label Image

3193-11 Container Label (Cefepime For Injection In Duplex 7)

FDA Label Image

3195-11 Container Label (Cefepime For Injection In Duplex 8)

3195-11 Container Label (Cefepime For Injection In Duplex 8)
This is a description of a medical product. It is a single-dose sterile and nonpyrogenic solution containing Cefepime Hydrochloride USP equivalent to 1 g of cefepime and L-arginine for pH adjustment. This solution is meant for IV use only and comes in a 50 mL Duplex container. The product must be used within 7 days of peeling the foil strip, but not beyond the labeled expiration date. The reconstitution process involves folding the container and squeezing the diluent chamber until the seal opens and releases diluent into the drug chamber, followed by squeezing the container again until the seal between drug chamber and set port opens. The product is not made with natural rubber latex, PVC or DEHP. Further information on reconstitution and administration is available in the package insert of the product.*
FDA Label Image

Display Panel Drug Barrier Strip (Cefepime For Injection In Duplex 9)

Display Panel Drug Barrier Strip (Cefepime For Injection In Duplex 9)
Cefepime and Dextrose Injection is a sterile and non-pyrogenic intravenous solution containing Cefepime Hydrochloride USP equivalent to 2g of cefepime with L-arginine for pH adjustment. After reconstitution, each 50 mL single-dose unit contains Cefepime for Injection and approximately 5% w/v of Hydrous Dextrose USP in Water for Injection USP. It is used for the treatment of bacterial infections. The solution must be used within 7 days of sealing the foil strip and it should be protected from light. The solution should be clear and free from particulate matter before use. The complete directions for reconstitution and administration can be found in the package insert. This product is not made with natural rubber latex, FVC, or DEHP. It is recommended to check for minute leaks before administration. The product must be kept between 15-30°C, and it should not be frozen.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.